Junji Yonese
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Prostate Cancer Treatment and Research 64
- Prostate Cancer Diagnosis and Treatment 48
- Renal cell carcinoma treatment 43
- Urology 22
- Co-authors
- Iwao FukuiShinya YamamotoTakeshi YuasaYasuhisa FujiiSatoru KawakamiYoshinobu KomaiYuichi IshikawaHitoshi Masuda
- Journals
- International Journal of Urology (24 papers)International Journal of Clinical Oncology (19 papers)Urology (13 papers)The Journal of Urology (10 papers)Anticancer Research (7 papers)
- Partner nations
- JapanUnited StatesIndia
In The Last Decade
Junji Yonese
195 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 96
- Pulmonary and Respiratory Medicine 1.9k
- Oncology 997
- Cancer Research 422
- Urology 160
- Rheumatology 284
Countries citing papers authored by Junji Yonese
This map shows the geographic impact of Junji Yonese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Yonese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Yonese more than expected).
Fields of papers citing papers by Junji Yonese
This network shows the impact of papers produced by Junji Yonese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Yonese. The network helps show where Junji Yonese may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junji Yonese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 3 | |
| 6 | Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma | 2019 | 2 |
| 7 | 2018 | 1 | |
| 8 | 2017 | 15 | |
| 9 | 2014 | 38 | |
| 10 | 2013 | 23 | |
| 11 | 2011 | 29 | |
| 12 | 2010 | 16 | |
| 13 | 2008 | 30 | |
| 14 | 2007 | 130 | |
| 15 | 2006 | 14 | |
| 16 | 2004 | 2 | |
| 17 | 1998 | 1 | |
| 18 | [Leiomyosarcoma of the prostate: a case report of remission for 9 years by radiotherapy]. | 1995 | 5 |
| 19 | 1994 | 1 | |
| 20 | 1993 | 5 |
About Junji Yonese
Junji Yonese is a scholar working on Pulmonary and Respiratory Medicine, Urology, Oncology, Surgery and Cancer Research, having authored 207 papers that have together received 2.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (64 papers), Bladder and Urothelial Cancer Treatments (50 papers), Prostate Cancer Diagnosis and Treatment (48 papers), Renal cell carcinoma treatment (43 papers), Urinary and Genital Oncology Studies (32 papers), Cancer Immunotherapy and Biomarkers (31 papers), Renal and related cancers (21 papers) and Urologic and reproductive health conditions (21 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.9k citations), Oncology (997 citations), Cancer Research (422 citations), Urology (160 citations) and Rheumatology (284 citations). Junji Yonese has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Iwao Fukui, Shinya Yamamoto, Takeshi Yuasa, Yasuhisa Fujii, Satoru Kawakami, Yoshinobu Komai, Yuichi Ishikawa, Hitoshi Masuda, Kazunori Kihara and Kazutaka Saito. Their work appears in journals such as International Journal of Urology, International Journal of Clinical Oncology, Urology, The Journal of Urology and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.